Agilent Technologies (NYSE:A) Issues FY 2025 Earnings Guidance

Agilent Technologies (NYSE:A) updated its FY 2025 earnings guidance on Wednesday. The company provided earnings per share guidance of 5.540-5.610 for the period, compared to the consensus earnings per share estimate of 5.570. The company issued revenue guidance of $6.7 billion-$6.8 billion, compared to the consensus revenue estimate of $6.8 billion. Agilent Technologies also updated its Q2 2025 guidance to 1.250-1.280 EPS.

Agilent Technologies Price Performance

NYSE A traded down $5.91 during mid-day trading on Thursday, hitting $128.56. The stock had a trading volume of 860,993 shares, compared to its average volume of 1,652,657. The firm’s 50 day moving average is $140.90 and its 200 day moving average is $139.28. The company has a debt-to-equity ratio of 0.57, a current ratio of 2.09 and a quick ratio of 1.58. The stock has a market capitalization of $36.68 billion, a price-to-earnings ratio of 29.12, a PEG ratio of 3.63 and a beta of 1.07. Agilent Technologies has a twelve month low of $124.16 and a twelve month high of $155.35.

Agilent Technologies (NYSE:A) last posted its quarterly earnings results on Wednesday, February 26th. The medical research company reported $1.31 EPS for the quarter, beating the consensus estimate of $1.27 by $0.04. The firm had revenue of $1.68 billion during the quarter, compared to analysts’ expectations of $1.67 billion. Agilent Technologies had a return on equity of 25.43% and a net margin of 19.80%. Equities research analysts forecast that Agilent Technologies will post 5.56 earnings per share for the current fiscal year.

Agilent Technologies Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, April 23rd. Stockholders of record on Tuesday, April 1st will be paid a $0.248 dividend. The ex-dividend date of this dividend is Tuesday, April 1st. This represents a $0.99 annualized dividend and a dividend yield of 0.77%. Agilent Technologies’s dividend payout ratio (DPR) is 22.40%.

Wall Street Analysts Forecast Growth

Several brokerages recently issued reports on A. JPMorgan Chase & Co. reduced their price objective on shares of Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating on the stock in a report on Tuesday, November 26th. Robert W. Baird dropped their price objective on Agilent Technologies from $161.00 to $159.00 and set an “outperform” rating for the company in a research note on Thursday. Citigroup raised their target price on Agilent Technologies to $165.00 and gave the company a “buy” rating in a report on Thursday, December 19th. Wells Fargo & Company dropped their target price on Agilent Technologies from $157.00 to $155.00 and set an “overweight” rating for the company in a research report on Monday, December 9th. Finally, Bank of America reduced their price target on shares of Agilent Technologies from $153.00 to $150.00 and set a “neutral” rating on the stock in a research report on Friday, December 13th. Seven analysts have rated the stock with a hold rating and eight have given a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $146.15.

Insider Transactions at Agilent Technologies

In other news, CEO Padraig Mcdonnell sold 1,911 shares of the company’s stock in a transaction dated Tuesday, January 21st. The stock was sold at an average price of $150.00, for a total transaction of $286,650.00. Following the completion of the transaction, the chief executive officer now directly owns 39,652 shares of the company’s stock, valued at approximately $5,947,800. This represents a 4.60 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.